Rapido Trial 2024. Diseases of the colon & rectum Rapido was an international, phase iii randomized trial of total neoadjuvant therapy involving a short course of radiation followed by six courses of capox.
Diseases of the colon & rectum Locoregional recurrence in the rapido trial and the importance of the quality of the resected specimen:
Rapido Was An International, Phase Iii Randomized Trial Of Total Neoadjuvant Therapy Involving A Short Course Of Radiation Followed By Six Courses Of Capox.
The project will report full results in 2024 and is funded by astrazeneca.
A Major Advance Has Been Made In The Management Of Rectal Cancer, With The Emergence In 2021 Of Total Neoadjuvant Treatment.
The main publications from the.
Locoregional Recurrence In The Rapido Trial And The Importance Of The Quality Of The Resected Specimen:
Images References :
To Analyze Risk And Patterns Of Locoregional Failure (Lrf) In Patients Of The Rapido Trial At 5 Years.
Rapido was an international, phase iii randomized trial of total neoadjuvant therapy involving a short course of radiation followed by six courses of capox.
The Rapido Trial Included 920 Patients With Locally Advanced Rectal Cancer Randomized To Standard Chemoradiation Therapy And Then Surgery After A Delay Of Eight.
Locoregional recurrence in the rapido trial and the importance of the quality of the resected specimen:
The Project Will Report Full Results In 2024 And Is Funded By Astrazeneca.